Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    October 2018
  1. CRESSEY TR, Harrison L, Achalapong J, Kanjanavikai P, et al
    Tenofovir exposure during pregnancy and postpartum in women receiving tenofovir disoproxil fumarate for the prevention of mother-to-child transmission of hepatitis B virus.
    Antimicrob Agents Chemother. 2018 Oct 1. pii: AAC.01686.
    PubMed     Text format     Abstract available


    September 2018
  2. DIAN S, Yunivita V, Ganiem AR, Pramaesya T, et al
    A double-blinded randomised placebo-controlled phase II trial to evaluate high dose rifampicin for tuberculous meningitis: a dose finding study.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01014.
    PubMed     Text format     Abstract available


  3. GOMES A, Ferraz R, Ficker L, Collins MS, et al
    Chloroquine analogues as leads against Pneumocystis lung pathogens.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.00983.
    PubMed     Text format     Abstract available


    August 2018
  4. BANDA CG, Dzinjalamala F, Mukaka M, Mallewa J, et al
    Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in falciparum-negative HIV-infected Malawian adults stabilized on antiretrovira
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01162.
    PubMed     Text format     Abstract available


  5. SPIVAK AM, Nell RA, Petersen M, Martins L, et al
    Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01361.
    PubMed     Text format     Abstract available


  6. INNES S, van der Laan L, Anderson PL, Cotton M, et al
    CAN WE IMPROVE STAVUDINE'S SAFETY PROFILE IN CHILDREN? PHARMACOKINETICS OF INTRACELLULAR STAVUDINE-TRIPHOSPHATE WITH REDUCED-DOSING.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.00761.
    PubMed     Text format     Abstract available


  7. KANDLER JL, Mercante AD, Dalton TL, Ezewudo MN, et al
    Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00974.
    PubMed     Text format     Abstract available


  8. ADEGBOLA A, Abutaima R, Olagunju A, Ijarotimi O, et al
    Effect of pregnancy on the pharmacokinetic interaction between efavirenz and lumefantrine in HIV-malaria co-infection.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.01252.
    PubMed     Text format     Abstract available


  9. DOOKIE N, Naidoo K, Padayatchi N
    Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    July 2018
  10. MILLER JT, Zhao H, Masaoka T, Varnado B, et al
    Sensitivity of the C-terminal nuclease domain of Kaposi's sarcoma-associated herpesvirus ORF29 to two classes of active site ligands.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00233.
    PubMed     Text format     Abstract available


  11. SMITH RA, Wu VH, Zavala CG, Raugi DN, et al
    In vitro antiviral activity of cabotegravir against HIV-2.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.01299.
    PubMed     Text format     Abstract available


  12. BARRETT SE, Teller RS, Forster SP, Li L, et al
    Extended Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.01058.
    PubMed     Text format     Abstract available


  13. KANWAR A, Cadnum JL, Jencson AL, Donskey CJ, et al
    Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus Among Hospitalized Patients.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00609.
    PubMed     Text format     Abstract available


  14. SMITH SJ, Zhao XZ, Burke TR Jr, Hughes SH, et al
    HIV-1 integrase inhibitors that are broadly effective against drug-resistant mutants.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01035.
    PubMed     Text format     Abstract available


  15. MEHTA R, Wolstenholme A, Di Lullo K, Fu C, et al
    Bioequivalence of a Fixed-Dose Combination Tablet of the Complete 2-Drug Regimen Dolutegravir and Rilpivirine for the Treatment of HIV-1 Infection.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00748.
    PubMed     Text format     Abstract available


    June 2018
  16. ANKROM W, Yee KL, Sanchez RI, Adedoyin A, et al
    Severe Renal Impairment Has Minimal Impact on Doravirine Pharmacokinetics.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00326.
    PubMed     Text format     Abstract available


    May 2018
  17. SPADARI CC, Vila T, Rozental S, Ishida K, et al
    Miltefosine has post-antifungal effect and induces apoptosis in Cryptococcus yeasts.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.00312.
    PubMed     Text format     Abstract available


  18. BANDA CG, Dzinjalamala F, Mukaka M, Mallewa J, et al
    Pharmacokinetics of piperaquine and safety profile of dihydroartemisinin-piperaquine co-administered with antiretroviral therapy in malaria-uninfected HIV-positive Malawian adults.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00634.
    PubMed     Text format     Abstract available


  19. YEW WW, Chang KC, Chan DP
    Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.02637.
    PubMed     Text format     Abstract available


  20. BANDA CG, Dzinjalamala F, Mukaka M, Mallewa J, et al
    Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00412.
    PubMed     Text format     Abstract available


  21. FOCA E, Calcagno A, Bonito A, Cusato J, et al
    Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00309.
    PubMed     Text format     Abstract available


  22. AMMERMAN NC, Swanson RV, Bautista EM, Almeida DV, et al
    Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00636.
    PubMed     Text format     Abstract available


    April 2018
  23. STADER F, Kinvig H, Battegay M, Khoo S, et al
    Analysis of clinical drug-drug interaction data to predict uncharacterized interaction magnitudes between antiretroviral drugs and co-medications.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00717.
    PubMed     Text format     Abstract available


  24. MOURE R, Domingo P, Villarroya J, Gasa L, et al
    Reciprocal effects of antiretroviral drugs used to treat HIV infection on the fibroblast growth factor-21/beta-Klotho system.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00029.
    PubMed     Text format     Abstract available


    March 2018
  25. ENOSI TUIPULOTU D, Netzler NE, Lun JH, Mackenzie JM, et al
    TLR7 agonists display potent antiviral effects against norovirus infection via innate stimulation.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02417.
    PubMed     Text format     Abstract available


    February 2018
  26. LE HN, Quetz JS, Tran VG, Le VTM, et al
    MEDI3902 correlates of protection against severe Pseudomonas aeruginosa pneumonia in a rabbit acute pneumonia model.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.02565.
    PubMed     Text format     Abstract available


  27. DELINO NS, Aoki M, Hayashi H, Hattori SI, et al
    GRL-079, a novel P2-Tp-THF-C5-alkylamine- and P2' -Abt-containing HIV-1 protease inhibitor, is extremely potent against multi-drug-resistant HIV-1 variants including HIVDRV(R)p51 and has a high genetic barrier against the emergence of resistant varian
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02060.
    PubMed     Text format     Abstract available


    January 2018
  28. UCHIYA KI, Asahi S, Futamura K, Hamaura H, et al
    Antibiotic susceptibility and genotyping of Mycobacterium avium strains that cause pulmonary and disseminated infection.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02035.
    PubMed     Text format     Abstract available


    November 2017
  29. KAKADIYA PP, Higginson RT, Fulco PP
    Ritonavir-boosted protease inhibitors but not cobicistat appear safe in HIV-positive patients ingesting dabigatran.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.02275.
    PubMed     Text format     Abstract available


  30. DENTI P, Garcia-Prats AJ, Draper HR, Wiesner L, et al
    Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01521.
    PubMed     Text format     Abstract available


  31. VAN DER LAAN LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, et al
    Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.00420.
    PubMed     Text format     Abstract available


    October 2017
  32. XIAO P, Gumber S, Marzinke MA, Date AA, et al
    Hypo-osmolar formulation of TFV enema promotes uptake and metabolism of TFV in tissues and leading to prevention of SHIV/SIV infection.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01644.
    PubMed     Text format     Abstract available


  33. HERRERO-FERNANDEZ I, Pacheco YM, Genebat M, Rodriguez-Mendez MDM, et al
    Association between a suppressor combined antiretroviral therapy containing Maraviroc and the hepatitis B virus vaccine response.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.02050.
    PubMed     Text format     Abstract available


  34. HEALAN AM, Griffiss JM, Proskin HM, O'Riordan MA, et al
    Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics: A Randomized Clinical Trial in Healthy Adult Volunteers.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.00855.
    PubMed     Text format     Abstract available


  35. ANDERSON PL, Liu AY, Castillo-Mancilla JR, Gardner EM, et al
    Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy: the DOT-DBS Study.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01710.
    PubMed     Text format     Abstract available


  36. SERRANO-VILLAR S, Caruana G, Zlotnik A, Perez-Molina JA, et al
    The effects of maraviroc versus efavirenz in combination with zidovudine/lamivudine on the CD4/CD8 ratio in treatment-naive HIV-infected individuals.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01763.
    PubMed     Text format     Abstract available


    September 2017
  37. ELOY P, Tessier A, Fan-Havard P, Chou M, et al
    Genetics of nevirapine metabolic pathways at steady state in HIV-infected Cambodians.
    Antimicrob Agents Chemother. 2017 Sep 25. pii: AAC.00733.
    PubMed     Text format     Abstract available


  38. HASSOUNAH SA, Alikhani A, Oliveira M, Bharaj S, et al
    Antiviral Activity of Bictegravir and Cabotegravir Against Integrase Inhibitor Resistant SIVmac239 and HIV-1.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01695.
    PubMed     Text format     Abstract available


  39. PATEL S, Leibrand CR, Palasuberniam P, Couraud PO, et al
    Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01307.
    PubMed     Text format     Abstract available


  40. ZHAO N, Wang G, Das AT, Berkhout B, et al
    Combinatorial CRISPR-Cas9 and RNAi attack on HIV-1 DNA and RNA can lead to cross-resistance.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01486.
    PubMed     Text format     Abstract available


  41. KOSAKA M, Ushiki A, Ikuyama Y, Hirai K, et al
    Efficacy and toxicity of low-dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis pneumonia in patients without human immunodeficiency virus infection: A four-center retrospective study.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01173.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: